Johnson & Johnson

Johnson & Johnson has announced its plans to acquire Neostrata, its affiliates and Tristrata Incorporated.

The acquisition enables Johnson & Johnson and Neostrata to discover and develop new important skincare solutions associated with human insights and compelling science.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

DNA2.0 has announced its plans to develop protein pharmaceutical research by employing unparalleled antibody production and engineering platform through acquisition of MIGS’s assets.

Pursuant to the transaction, Michael Feldhaus, the co-founder of MIGS, will join DNA2.0 team as senior vice-president of antibody technologies in Newark, California.

Image: Johnson & Johnson has announced its plans to acquire Neostrata; Photo: courtesy of Luis Gracia.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact